Safety and tolerability of diuretics withdrawal in heart failure with reduced ejection fraction. The REDICAE trial

Back

HFA Premium Access

Safety and tolerability of diuretics withdrawal in heart failure with reduced ejection fraction. The REDICAE trial

Session: Chronic heart failure - pathophysiology and mechanisms 7

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Speaker: Doctor J. Torres Zamudio (Cordoba, ES)

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Doctor Jesus Alberto Torres Zamudio

Reina Sofia University Hospital, Cordoba (Spain)

0 follower

4 more presentations in this session

Prognostic implications of adaptive and maladaptive right ventricular hypertrophy in patients with heart failure: a prospective observational cohort study

Speaker: Doctor L. Dinc Asarcikli (Istanbul, TR)

Predictors of early left ventricular reverse remodelling and prognosis in new-onset heart failure of non-ischemic origin

Speaker: Doctor T. Hnat (Prague, CZ)

Dapagliflozin's influence on cardiac remodeling in chronic heart failure patients

Speaker: Doctor A. Ribeiro Teixeira (Lisbon, PT)

Cardiac reverse remodeling and SGLT2ii: insight from hemodynamic forces analysis

Speaker: Doctor S. Prosperi (Rome, IT)

Access the full session

Chronic heart failure - pathophysiology and mechanisms 7

Speakers: Doctor J. Torres Zamudio, Doctor L. Dinc Asarcikli, Doctor T. Hnat, Doctor A. Ribeiro Teixeira, Doctor S. Prosperi

Access

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources